The impact of the COVID-19 pandemic on cancer care

The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nature cancer Ročník 1; číslo 6; s. 565 - 567
Hlavní autoři: Richards, Mike, Anderson, Michael, Carter, Paul, Ebert, Benjamin L., Mossialos, Elias
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Nature Publishing Group 01.06.2020
Témata:
Cancer surgery
Cancer therapies
Chemotherapy
Clinical trials
COVID-19
COVID-19 diagnostic tests
Disease transmission
Elective surgery
Endoscopy
Gastroenterology
Hospitals
Infections
Medical screening
Oncology
Pandemics
Patients
Radiation therapy
Severe acute respiratory syndrome coronavirus 2
United Kingdom > UK
England
United States > US
Health services
Oncology
Health policy
ISSN:2662-1347, 2662-1347
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The COVID-19 pandemic has disrupted the spectrum of cancer care, including delaying diagnoses and treatment and halting clinical trials. In response, healthcare systems are rapidly reorganizing cancer services to ensure that patients continue to receive essential care while minimizing exposure to SARS-CoV-2 infection.
Bibliografie:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:2662-1347
2662-1347
DOI:10.1038/s43018-020-0074-y